Breastfeeding and Gut Health (PENSINE)

July 4, 2022 updated by: University Hospital, Lille

Influence of Breastfeeding on Gut Health in Children

The aim of the study is to evaluate the impact of early nutrition on gut health in children. A prospective cohort of newborns will be recruited at birth and followed up to 4 years of age. Information on parent's nutritional habits and life style, breastfeeding duration and child's complementary feeding, will be collected. Cord blood cells and stools will be collected at birth, 6 months, 2 years and 4 years of age for implementing a biological collection. Gut health will be evaluated in children during the first four years of life based on fecal secretory immunoglobulin A (SIgA) and presence of digestive symptoms. Precise data on breastfeeding practices and their short- and medium-term effects on the health of the child, in particular and in an innovative way on gut health, will be obtained.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Lille, France, 59037
        • Recruiting
        • Hop Jeanne de Flandre Chu Lille
        • Principal Investigator:
          • Delphine LEY, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Monocentric cohort including mother/child dyads recruited in a University Maternity

Description

Inclusion Criteria:

For the mother:

  • Pregnant woman (>18 years old) followed at the Lille University Jeanne de Flandres Maternity
  • Woman who can speak, read and write in French
  • Single pregnancy
  • Informed consent
  • Living in the Lille area

For the father:

  • Men >18 years old
  • Informed consent

Exclusion Criteria:

For the mother:

  • Impossibility to participate to the study follow-up
  • Woman under guardianship or curatorship
  • Woman involved in another study inconsistent with biological samples collection

For the child after birth:

  • Prematurity <37 weeks
  • Impossibility to participate to the study follow-up
  • Child under judicial protection measure
  • Child involved in another study inconsistent with biological samples collection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Correlation between exclusive breastfeeding and gut health based on the non-invasive measurement of fecal secretory immunoglobulin A (sIgA)
Time Frame: AT 4 years
AT 4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between gut health and the duration of exclusive breastfeeding
Time Frame: A 1 month, 1-2 months, 2-4 months, 4-6 months, 6 months
defined by the production of Igas in the faeces and the duration of exclusive breastfeeding (1 month, 1-2 months, 2-4 months, 4-6 months, 6 months) collected by mother's interrogation.
A 1 month, 1-2 months, 2-4 months, 4-6 months, 6 months
Correlation between the mother's feeding habits during pregnancy and the child's gut health during the first 4 years of life
Time Frame: At 6 months, 2 years and 4 years
Nutritional data collected via the Food Frequency Questionnaire (FFQ) and the mother's obstetric record and Intestinal health of the child during the first 4 years of life evaluated by the production of Igas
At 6 months, 2 years and 4 years
Correlation between sIgA and child growth and gastro-intestinal disorders
Time Frame: At 6 months, 2 years and 4 years
defined by Production of Igas in children and the head circumference, weight and height of the child reported in the health log and the presence of gastrointestinal symptoms evaluated according to the criteria of ROME IV.
At 6 months, 2 years and 4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Delphine Ley, MD, University Hospital, Lille

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 17, 2020

Primary Completion (Anticipated)

December 1, 2025

Study Completion (Anticipated)

December 1, 2025

Study Registration Dates

First Submitted

December 4, 2019

First Submitted That Met QC Criteria

December 10, 2019

First Posted (Actual)

December 11, 2019

Study Record Updates

Last Update Posted (Actual)

July 6, 2022

Last Update Submitted That Met QC Criteria

July 4, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2018_67
  • 2019-A01416-51 (Other Identifier: ID-RCB number,ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gut Health

3
Subscribe